Hypocholesterolemia in chronic anemias with increased erythropoietic activity

Hanna Shalev1, Joseph Kapelushnik, Asher Moser

  • 1Pediatric Clinic Center, General Health Services (Kupat-Holim Clalit), Rahat and Faculty of Medicine, Ben Gurion University of the Negev, Beer Sheva, Israel.

Insights

Hypocholesterolemia, or low cholesterol, is linked to anemias with high red blood cell production. This suggests increased cholesterol use by active bone marrow, potentially impacting cardiovascular health.

Area of Science:

  • Hematology
  • Clinical Biochemistry

Background:

  • Hypocholesterolemia is observed in chronic anemias.
  • Previous studies suggest a potential link between low cholesterol and reduced atherosclerotic events in anemic patients.

Purpose of the Study:

  • To investigate the prevalence of hypocholesterolemia across different types of anemia.
  • To explore the relationship between erythropoietic activity and serum lipid levels.

Main Methods:

  • Serum levels of cholesterol, HDL, LDL, triglycerides, hemoglobin, ferritin, soluble transferrin receptor (STR), and erythropoietin were measured.
  • Patients were categorized into groups based on high or low erythropoietic activity, alongside healthy controls.

Main Results:

  • All patients with high erythropoietic activity anemias exhibited hypocholesterolemia.
  • Significantly lower serum cholesterol, HDL, and LDL levels were found in the high erythropoietic activity group compared to controls and the low erythropoietic activity group.
  • An inverse correlation was observed between serum cholesterol and STR levels, indicating a link with bone marrow activity.

Conclusions:

  • Hypocholesterolemia is associated with anemias characterized by high erythropoietic activity.
  • Increased cholesterol demand by proliferating erythroid cells is proposed as the underlying mechanism.
  • Further research is warranted to understand the precise mechanisms and clinical implications.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...